Filing Details

Accession Number:
0001127602-19-033520
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 06:23:27
Reporting Period:
2019-11-20
Accepted Time:
2019-11-22 06:23:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1171527 Barton Peter Hutt C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-20 200,000 $0.04 203,924 No 4 M Direct
Common Stock Disposition 2019-11-20 200,000 $20.18 3,924 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-20 200,000 $0.00 200,000 $0.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
502,752 2022-03-27 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares sold in multiple transactions at prices ranging from $20.00 to $20.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  2. This option is fully vested and exercisable.